In one paragraphArticle in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Taiane N SouzaDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0002-5500-7758 Haroldo C de OliveiraInstituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil.
Antonio S NakouziDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Marlon D M SantosInstituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil.
Daniel Zamith-MirandaDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0001-7532-2432 Joshua D NosanchukDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0001-9905-5754 Liise-Anne PirofskiDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0002-7568-2961 Funding
The biology of Cryptococcus neoformans melanizationR01AI171093 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall, JOSHUA D NOSANCHUK · 2023 to 2026
$3.2MAntibodies, B cells and resistance to human cryptococcosisR01AI143453 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PIROFSKI, LIISE-ANNE · 2019 to 2024
$3.2MCandida auris extracellular vesicles subvert host immune responsesR21AI156104 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI NOSANCHUK, JOSHUA D · 2021 to 2022
$462kAn extracellular vesicle component as a candidate to control cryptococcosis.R01AI183314 · NIAID · FUNDACAO OSWALDO CRUZ · PI JOSHUA D NOSANCHUK, Marcio Lourenco Rodrigues · 2024 to 2026
$380kNIAID NIH HHS R01 AI143453NIAID NIH HHS R01 AI171093NIAID NIH HHS R01 AI183314NIAID NIH HHS R21 AI156104
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Cryptococcus neoformansFungal ProteinsImmunoglobulinsProteomeCoculture TechniquesFungal CapsulesHumansImmunoglobulin AImmunoglobulin GImmunoglobulin MMeningitis, CryptococcalPolysaccharidesFungal ProteinsglucuronoxylomannanImmunoglobulin AImmunoglobulin GImmunoglobulin MImmunoglobulinsPolysaccharidesProteomecryptococcal capsulecryptococcal meninigitscryptococcal pathogenesiscryptococcal proteomeCryptococcus neoformansglucuronoxylomannanHIV-associated complicationshuman immunoglobulinsIgAIgGIgM
Identifiers
PMID41660986
PMCPMC12977590
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390